ASH2022注目テーマ③「Late-Breaking Abstracts Session #3」

中枢神経系原発悪性リンパ腫の地固め療法として
大量化学療法と幹細胞移植は予後を改善する Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43) (#LBA-3)

Gerald Illerhaus（Oncology Stem Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany）